An Ethical Exploration of Barriers to Research on Controlled Drugs

Michael H. Andreae, Evelyn Rhodes, Tyler Bourgoise, George M. Carter, Robert S. White, Debbie Indyk, Henry Sacks, Rosamond Rhodes

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

We examine the ethical, social, and regulatory barriers that may hinder research on therapeutic potential of certain controversial controlled substances like marijuana, heroin, or ketamine. Hazards for individuals and society and potential adverse effects on communities may be good reasons for limiting access and justify careful monitoring of these substances. Overly strict regulations, fear of legal consequences, stigma associated with abuse and populations using illicit drugs, and lack of funding may, however, limit research on their considerable therapeutic potential. We review the surprisingly sparse literature and address the particular ethical concerns pertinent to research with illicit and addictive substances, such as undue inducement, informed consent, therapeutic misconception, and risk to participants, researchers, and institutions. We consider the perspectives of key research stakeholders and explore whether they may be infected with bias. We conclude by proposing an empirical research agenda to provide an evidentiary basis for ethical reasoning.

Original languageEnglish (US)
Pages (from-to)36-47
Number of pages12
JournalAmerican Journal of Bioethics
Volume16
Issue number4
DOIs
StatePublished - Apr 2 2016

Fingerprint

Therapeutic Misconception
Controlled Substances
Research
Pharmaceutical Preparations
Therapeutic Human Experimentation
Empirical Research
Heroin
Ketamine
Street Drugs
Cannabis
Informed Consent
Fear
Research Personnel
Population
Therapeutics

Keywords

  • biomedical research
  • confidentiality and privacy
  • human subjects research
  • informed consent
  • institutional review board
  • research ethics

ASJC Scopus subject areas

  • Health Policy
  • Issues, ethics and legal aspects

Cite this

Andreae, M. H., Rhodes, E., Bourgoise, T., Carter, G. M., White, R. S., Indyk, D., ... Rhodes, R. (2016). An Ethical Exploration of Barriers to Research on Controlled Drugs. American Journal of Bioethics, 16(4), 36-47. https://doi.org/10.1080/15265161.2016.1145282

An Ethical Exploration of Barriers to Research on Controlled Drugs. / Andreae, Michael H.; Rhodes, Evelyn; Bourgoise, Tyler; Carter, George M.; White, Robert S.; Indyk, Debbie; Sacks, Henry; Rhodes, Rosamond.

In: American Journal of Bioethics, Vol. 16, No. 4, 02.04.2016, p. 36-47.

Research output: Contribution to journalArticle

Andreae, MH, Rhodes, E, Bourgoise, T, Carter, GM, White, RS, Indyk, D, Sacks, H & Rhodes, R 2016, 'An Ethical Exploration of Barriers to Research on Controlled Drugs', American Journal of Bioethics, vol. 16, no. 4, pp. 36-47. https://doi.org/10.1080/15265161.2016.1145282
Andreae MH, Rhodes E, Bourgoise T, Carter GM, White RS, Indyk D et al. An Ethical Exploration of Barriers to Research on Controlled Drugs. American Journal of Bioethics. 2016 Apr 2;16(4):36-47. https://doi.org/10.1080/15265161.2016.1145282
Andreae, Michael H. ; Rhodes, Evelyn ; Bourgoise, Tyler ; Carter, George M. ; White, Robert S. ; Indyk, Debbie ; Sacks, Henry ; Rhodes, Rosamond. / An Ethical Exploration of Barriers to Research on Controlled Drugs. In: American Journal of Bioethics. 2016 ; Vol. 16, No. 4. pp. 36-47.
@article{4a7c2aa59c2a42638c24b104f9bd3121,
title = "An Ethical Exploration of Barriers to Research on Controlled Drugs",
abstract = "We examine the ethical, social, and regulatory barriers that may hinder research on therapeutic potential of certain controversial controlled substances like marijuana, heroin, or ketamine. Hazards for individuals and society and potential adverse effects on communities may be good reasons for limiting access and justify careful monitoring of these substances. Overly strict regulations, fear of legal consequences, stigma associated with abuse and populations using illicit drugs, and lack of funding may, however, limit research on their considerable therapeutic potential. We review the surprisingly sparse literature and address the particular ethical concerns pertinent to research with illicit and addictive substances, such as undue inducement, informed consent, therapeutic misconception, and risk to participants, researchers, and institutions. We consider the perspectives of key research stakeholders and explore whether they may be infected with bias. We conclude by proposing an empirical research agenda to provide an evidentiary basis for ethical reasoning.",
keywords = "biomedical research, confidentiality and privacy, human subjects research, informed consent, institutional review board, research ethics",
author = "Andreae, {Michael H.} and Evelyn Rhodes and Tyler Bourgoise and Carter, {George M.} and White, {Robert S.} and Debbie Indyk and Henry Sacks and Rosamond Rhodes",
year = "2016",
month = "4",
day = "2",
doi = "10.1080/15265161.2016.1145282",
language = "English (US)",
volume = "16",
pages = "36--47",
journal = "American Journal of Bioethics",
issn = "1526-5161",
publisher = "Routledge",
number = "4",

}

TY - JOUR

T1 - An Ethical Exploration of Barriers to Research on Controlled Drugs

AU - Andreae, Michael H.

AU - Rhodes, Evelyn

AU - Bourgoise, Tyler

AU - Carter, George M.

AU - White, Robert S.

AU - Indyk, Debbie

AU - Sacks, Henry

AU - Rhodes, Rosamond

PY - 2016/4/2

Y1 - 2016/4/2

N2 - We examine the ethical, social, and regulatory barriers that may hinder research on therapeutic potential of certain controversial controlled substances like marijuana, heroin, or ketamine. Hazards for individuals and society and potential adverse effects on communities may be good reasons for limiting access and justify careful monitoring of these substances. Overly strict regulations, fear of legal consequences, stigma associated with abuse and populations using illicit drugs, and lack of funding may, however, limit research on their considerable therapeutic potential. We review the surprisingly sparse literature and address the particular ethical concerns pertinent to research with illicit and addictive substances, such as undue inducement, informed consent, therapeutic misconception, and risk to participants, researchers, and institutions. We consider the perspectives of key research stakeholders and explore whether they may be infected with bias. We conclude by proposing an empirical research agenda to provide an evidentiary basis for ethical reasoning.

AB - We examine the ethical, social, and regulatory barriers that may hinder research on therapeutic potential of certain controversial controlled substances like marijuana, heroin, or ketamine. Hazards for individuals and society and potential adverse effects on communities may be good reasons for limiting access and justify careful monitoring of these substances. Overly strict regulations, fear of legal consequences, stigma associated with abuse and populations using illicit drugs, and lack of funding may, however, limit research on their considerable therapeutic potential. We review the surprisingly sparse literature and address the particular ethical concerns pertinent to research with illicit and addictive substances, such as undue inducement, informed consent, therapeutic misconception, and risk to participants, researchers, and institutions. We consider the perspectives of key research stakeholders and explore whether they may be infected with bias. We conclude by proposing an empirical research agenda to provide an evidentiary basis for ethical reasoning.

KW - biomedical research

KW - confidentiality and privacy

KW - human subjects research

KW - informed consent

KW - institutional review board

KW - research ethics

UR - http://www.scopus.com/inward/record.url?scp=84961251933&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961251933&partnerID=8YFLogxK

U2 - 10.1080/15265161.2016.1145282

DO - 10.1080/15265161.2016.1145282

M3 - Article

C2 - 26982922

AN - SCOPUS:84961251933

VL - 16

SP - 36

EP - 47

JO - American Journal of Bioethics

JF - American Journal of Bioethics

SN - 1526-5161

IS - 4

ER -